Abeona Therapeutics Inc.
ABEO
$5.29
$0.428.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.16M | 108.83M | -12.03M | -9.29M | -30.27M |
| Total Depreciation and Amortization | 888.00K | 768.00K | 815.00K | 776.00K | 722.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 111.00K | -144.04M | -3.77M | -4.21M | 17.49M |
| Change in Net Operating Assets | -17.03M | 15.65M | -3.42M | -3.84M | -178.00K |
| Cash from Operations | -21.19M | -18.78M | -18.40M | -16.56M | -12.23M |
| Capital Expenditure | -2.52M | -2.90M | -1.40M | -606.00K | -404.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -62.11M | 158.79M | 5.61M | 19.48M | -5.76M |
| Cash from Investing | -64.63M | 155.89M | 4.21M | 18.88M | -6.17M |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.16M | 10.50M | 6.80M | 5.51M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -6.00K | -31.00K | -199.00K | -299.00K |
| Cash from Financing | 5.16M | 10.50M | 6.77M | 5.31M | -299.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -80.65M | 147.60M | -7.42M | 7.63M | -18.70M |